These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 1911545

  • 1. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells.
    Kannagi M, Harada S, Maruyama I, Inoko H, Igarashi H, Kuwashima G, Sato S, Morita M, Kidokoro M, Sugimoto M.
    Int Immunol; 1991 Aug; 3(8):761-7. PubMed ID: 1911545
    [Abstract] [Full Text] [Related]

  • 2. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells.
    Kannagi M, Shida H, Igarashi H, Kuruma K, Murai H, Aono Y, Maruyama I, Osame M, Hattori T, Inoko H.
    J Virol; 1992 May; 66(5):2928-33. PubMed ID: 1373197
    [Abstract] [Full Text] [Related]

  • 3. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
    Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, Jacobson S.
    J Exp Med; 1993 Jun 01; 177(6):1567-73. PubMed ID: 8496677
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic T cell response and expression of the target antigen in HTLV-I infection.
    Kannagi M, Matsushita S, Shida H, Harada S.
    Leukemia; 1994 Apr 01; 8 Suppl 1():S54-9. PubMed ID: 8152305
    [Abstract] [Full Text] [Related]

  • 5. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis.
    Parker CE, Daenke S, Nightingale S, Bangham CR.
    Virology; 1992 Jun 01; 188(2):628-36. PubMed ID: 1374983
    [Abstract] [Full Text] [Related]

  • 6. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T, Yoshimitsu M, Akimoto M, White Y, Matsushita K, Soeda S, Shimeno H, Kubota R, Izumo S, Arima N.
    Hum Immunol; 2011 Nov 01; 72(11):1001-6. PubMed ID: 21851845
    [Abstract] [Full Text] [Related]

  • 7. Short communication an interferon-γ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian population.
    Best I, López G, Talledo M, MacNamara A, Verdonck K, González E, Tipismana M, Asquith B, Gotuzzo E, Vanham G, Clark D.
    AIDS Res Hum Retroviruses; 2011 Nov 01; 27(11):1207-12. PubMed ID: 21453202
    [Abstract] [Full Text] [Related]

  • 8. Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion.
    Utz U, Banks D, Jacobson S, Biddison WE.
    J Virol; 1996 Feb 01; 70(2):843-51. PubMed ID: 8551623
    [Abstract] [Full Text] [Related]

  • 9. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S.
    J Immunol; 1998 Jul 01; 161(1):482-8. PubMed ID: 9647259
    [Abstract] [Full Text] [Related]

  • 10. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.
    Takamori A, Hasegawa A, Utsunomiya A, Maeda Y, Yamano Y, Masuda M, Shimizu Y, Tamai Y, Sasada A, Zeng N, Choi I, Uike N, Okamura J, Watanabe T, Masuda T, Kannagi M.
    Retrovirology; 2011 Dec 07; 8():100. PubMed ID: 22151736
    [Abstract] [Full Text] [Related]

  • 11. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T, Akimoto M, Toji S, White Y, Suzuki S, Arima T, Suruga Y, Matsushita K, Shimeno H, Soeda S, Kubota R, Izumo S, Uozumi K, Arima N.
    J Med Virol; 2011 Mar 07; 83(3):501-9. PubMed ID: 21264872
    [Abstract] [Full Text] [Related]

  • 12. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
    Kubota R, Nagai M, Kawanishi T, Osame M, Jacobson S.
    AIDS Res Hum Retroviruses; 2000 Nov 01; 16(16):1705-9. PubMed ID: 11080814
    [Abstract] [Full Text] [Related]

  • 13. Expression of the target antigen for cytotoxic T lymphocytes on adult T-cell-leukemia cells.
    Kannagi M, Matsushita S, Harada S.
    Int J Cancer; 1993 Jun 19; 54(4):582-8. PubMed ID: 8514449
    [Abstract] [Full Text] [Related]

  • 14. Cellular immune surveillance against HTLV-I infected T lymphocytes in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Fujihara K, Itoyama Y, Yu F, Kubo C, Goto I.
    J Neurol Sci; 1991 Sep 19; 105(1):99-107. PubMed ID: 1795176
    [Abstract] [Full Text] [Related]

  • 15. An altered peptide ligand antagonizes antigen-specific T cells of patients with human T lymphotropic virus type I-associated neurological disease.
    Kubota R, Soldan SS, Martin R, Jacobson S.
    J Immunol; 2000 May 15; 164(10):5192-8. PubMed ID: 10799878
    [Abstract] [Full Text] [Related]

  • 16. HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load.
    Tanaka M, Takenouchi N, Arishima S, Matsuzaki T, Nozuma S, Matsuura E, Takashima H, Kubota R.
    Int J Mol Sci; 2024 Jun 22; 25(13):. PubMed ID: 38999966
    [Abstract] [Full Text] [Related]

  • 17. Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
    Furukawa K, Mori M, Ohta N, Ikeda H, Shida H, Furukawa K, Shiku H.
    J Clin Invest; 1994 Nov 22; 94(5):1830-9. PubMed ID: 7962528
    [Abstract] [Full Text] [Related]

  • 18. Short-term cultured autologous peripheral blood mononuclear cells as a potential immunogen to activate Tax-specific CTL response in adult T-cell leukemia patients.
    Ishizawa M, Ganbaatar U, Hasegawa A, Takatsuka N, Kondo N, Yoneda T, Katagiri K, Masuda T, Utsunomiya A, Kannagi M.
    Cancer Sci; 2021 Mar 22; 112(3):1161-1172. PubMed ID: 33410215
    [Abstract] [Full Text] [Related]

  • 19. Limited T cell receptor usage by HTLV-I tax-specific, HLA class I restricted cytotoxic T lymphocytes from patients with HTLV-I associated neurological disease.
    Elovaara I, Utz U, Smith S, Jacobson S.
    J Neuroimmunol; 1995 Dec 22; 63(1):47-53. PubMed ID: 8557824
    [Abstract] [Full Text] [Related]

  • 20. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients.
    Greten TF, Slansky JE, Kubota R, Soldan SS, Jaffee EM, Leist TP, Pardoll DM, Jacobson S, Schneck JP.
    Proc Natl Acad Sci U S A; 1998 Jun 23; 95(13):7568-73. PubMed ID: 9636190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.